News

US biotech fund BVF Parners has sold its stake in drug developer Syntara, thus exiting all of its ASX life sciences exposures ...
Q: My doctor is suggesting that I try taking one of those new weight loss drugs -- off-label -- to help me cut down on my alcohol consumption. Does this make any sense? -- Pat R., Ann Arbor, Michigan ...
The economic, commercial, and financial blockade that the United States has maintained against Cuba for more than six decades ...
Nyesom Wike, has commended US-trained physician, Dr Helen Mbakwe, for her patriotic return to Nigeria and the establishment of the country’s ...
Rheumatoid arthritis is a painful and disabling autoimmune disease that affects more than 1% of people worldwide. In the ...
This finding is important because paracetamol is the most widely used painkiller around the world. Doctors often recommend it ...
DelveInsight's “Vitiligo Treatment Market Insights, Epidemiology and Market Forecast – 2034” report delivers an in-depth ...
A new study finds that people who could lift 5 kilograms (roughly 11 pounds) were at higher risk of developing chronic health ...
Among patients with mNSCLC receiving ICIs, overall survival was similar between those with vs without coexisting RA.
Candid Therapeutics, Inc. ("Candid"), a clinical-stage biotechnology company redefining the treatment of autoimmune and ...
The Global Albumin Market is expected to grow at a rate of 6% by 2026. The development of albumin-based nanoparticles for drug delivery, high demand for albumin in R&D activities & clinical trials, ...
EULAR now recommends moving directly to biologic or targeted synthetic disease-modifying antirheumatic drugs if the initial ...